In a recent shipment of insulin syringes, hospital administrators discovered eight percent were unusable due to defects. You are concerned that future shipments may not meet the hospital's quality standard which requires 99.7 percent of the syringes to be acceptable. The null hypothesis states that the percent of unacceptable syringes shipped is equal to 0.3 percent. Describe the Type I and Type II errors with your study. What are the ramifications of making these errors (from a clinical perspective)?